Sphingolipids
Invitrogen™ NBD C6-Ceramide Complexed to BSA
Selective stain for Golgi apparatus in live and fixed cells
Invitrogen™ BODIPY™ TR Ceramide complexed to BSA
Can be used in sphingolipid transport and metabolism mechanisms
Invitrogen™ BODIPY™ FL C5-Ceramide complexed to BSA
Can be used in sphingolipid transport and metabolism mechanisms
Invitrogen™ BODIPY™ FL C5-Lactosylceramide complexed to BSA
The green-fluorescent BODIPY™ FL C5 lactosylceramide complexed to BSA can be used in sphingolipid transport and metabolism mechanisms.
Invitrogen™ NBD C6-Ceramide (6-((N-(7-Nitrobenz-2-Oxa-1,3-Diazol-4-yl)amino)hexanoyl)Sphingosine)
Selective stain for Golgi apparatus in live and fixed cells
Invitrogen™ BODIPY™ FL C5-Ceramide (N-(4,4-Difluoro-5,7-Dimethyl-4-Bora-3a,4a-Diaza-s-Indacene-3-Pentanoyl)Sphingosine)
Useful in cellular imaging and cell tracing and tracking
Apexbio Technology LLC CERAMIDE 25MG
Ceramide (CAS 3102-57-6) is a bioactive lipid molecule known to modulate diverse cellular processes including proliferation and differentiation It exerts its effects primarily by activating several serine/threonine protein phosphatases notably protein phosphatase-1 (PP1) protein phosphatase-2A (PP2A) and ceramide-activated protein phosphatase (CAPP) in vitro Due to its regulatory role in fundamental signaling pathways ceramide serves as a valuable research tool in investigations addressing cell cycle progression apoptosis and cellular homeostasis
Sigma Aldrich Fine Chemicals Biosciences Ceramide phosphorylethanol5MG
Ceramide phosphorylethanolamine is a phosphosphingolipid. It maintains the structural framework of the plasma membrane aids in the formation and functioning of plasma membrane lipid rafts cell signaling and transduction events. Ceramide phosphorylethanolamine modulates various cellular processes like growth differentiation apoptosis and angiogenesis.
Cayman Chemical C18 dIhydro CeramIde-d3d181mg
An AT1 receptor antagonist (IC50 0.0077 UM for the bovine adrenal cortex receptor) and active metabolite of olmesartan medoxomil selective for AT1 over AT2 (IC50 100 UM for the bovine cerebellar receptor) reduces contraction of isolated guinea pig aorta induced by angiotensin II (pD2 9.9) reduces the angiotensin II-induced pressor response in conscious normotensive rats at 0.01 and 0.03 mg/kg i.v.